Peptide–drug conjugates with different linkers for cancer therapy

M Alas, A Saghaeidehkordi, K Kaur - Journal of medicinal …, 2020 - ACS Publications
Drug conjugates are chemotherapeutic or cytotoxic agents covalently linked to targeting
ligands such as an antibody or a peptide via a linker. While antibody–drug conjugates …

Cell penetrating peptides: A versatile vector for co-delivery of drug and genes in cancer

MM Khan, N Filipczak, VP Torchilin - Journal of controlled release, 2021 - Elsevier
Biological barriers hamper the efficient delivery of drugs and genes to targeted sites. Cell
penetrating peptides (CPP) have the ability to rapidly internalize across biological …

Cell-penetrating peptides (CPPs): An overview of applications for improving the potential of nanotherapeutics

K Desale, K Kuche, S Jain - Biomaterials Science, 2021 - pubs.rsc.org
In the field of nanotherapeutics, gaining cellular entry into the cytoplasm of the target cell
continues to be an ultimate challenge. There are many physicochemical factors such as …

In situ activation of therapeutics through bioorthogonal catalysis

W Wang, X Zhang, R Huang, CM Hirschbiegel… - Advanced drug delivery …, 2021 - Elsevier
Bioorthogonal chemistry refers to any chemical reactions that can occur inside of living
systems without interfering with native biochemical processes, which has become a …

[HTML][HTML] Peptide–drug conjugates (PDCs): a novel trend of research and development on targeted therapy, hype or hope?

C Fu, L Yu, Y Miao, X Liu, Z Yu, M Wei - Acta Pharmaceutica Sinica B, 2023 - Elsevier
Peptide–drug conjugates (PDCs) are the next generation of targeted therapeutics drug after
antibody–drug conjugates (ADCs), with the core benefits of enhanced cellular permeability …

Enhanced activity of vancomycin by encapsulation in hybrid magnetic nanoparticles conjugated to a cell-penetrating peptide

W Zhang, R Taheri-Ledari, Z Hajizadeh, E Zolfaghari… - Nanoscale, 2020 - pubs.rsc.org
We describe a novel antibiotic delivery system based on magnetic nanoparticles (NPs)
conjugated to a cell-penetrating peptide (CPP). Silica-coated iron oxide NPs were produced …

Status update in the use of cell-penetrating peptides for the delivery of macromolecular therapeutics

K Kurrikoff, B Vunk, Ü Langel - Expert Opinion on Biological …, 2021 - Taylor & Francis
Introduction In this review, recent developments and applications with cell-penetrating
peptides (CPP) are discussed. CPPs are widely used tools for the delivery of various …

[HTML][HTML] Combination of cell-penetrating peptides with nanomaterials for the potential therapeutics of central nervous system disorders: a review

Y Zhang, P Guo, Z Ma, P Lu, D Kebebe… - Journal of …, 2021 - Springer
Although nanomedicine have greatly developed and human life span has been extended,
we have witnessed the soared incidence of central nervous system (CNS) diseases …

RGD peptide‐drug conjugates as effective dual targeting platforms: recent advances

L Battistini, K Bugatti, A Sartori, C Curti… - European Journal of …, 2021 - Wiley Online Library
In recent years, targeted therapies have raised increasing interest as effective strategies to
improve therapeutic efficiency, reduce the impact of adverse side effects, and overcome …

Identification of a PH-Responsive Peptide–Paclitaxel Conjugate as a Novel Drug with Improved Therapeutic Potential

SFA Rizvi, N Abbas, H Zhang… - Journal of Medicinal …, 2023 - ACS Publications
A highly sensitive, nontoxic, hydrophilic cell-penetrating peptide (CPP= c [RGDKLAK]) was
selected for the construction of an effective peptide–drug conjugate (PDC). A hydrophobic …